- Home
- /
- News
- /
- Target Identification/ Validation
- /
- August 2013
Target Identification/ Validation News for August 2013
Depression and anxiety disorders affect a great many people and though we have antidepressants to treat symptoms, we actually know little about how the chemistry behind them works
16 August, 2013
Cancer Research Technology (CRT), the commercial arm of Cancer Research UK, The Institute of Cancer Research, London, and , Merck Serono, a division of Merck KGaA, Darmstadt, Germany, have signed a licensing deal today extending a successful initial alliance to discover and develop anticancer drugs that block the WNT signalling pathway.
02 August, 2013